knowledge -WSS

knowledge

author：fashion 2025-09-29 01:36:11 - browse：32435

A view of different flags of the European Union Members. -- first opinion coverage from STAT — Ronald Wittek, Pool Photo via AP

Today, the criteria used to assess the clinical value of new pharmaceuticals and medical devices varies widely across Europe, making it more challenging for biopharma companies to efficiently launch products in multiple countries and contributing to the disparities in access across the continent.

But change is on the horizon: In less than 15 months, the European Union will establish and begin to implement a standardized, pan-EU framework, which all 27 of member states will be required to use to assess the clinical evidence of newly submitted products or devices. A key pillar of the EU’s Regulation on Health Technology Assessment (HTA), the Joint Clinical Assessment (JCA) aims to establish a single, transparent process to reduce redundant practices and bring life science innovation faster to patients in Europe — no matter where they live.

In a longstanding problem in Europe, access to — and the availability of — medication varies across the member states. For example, in Germany, 87% of products approved by the European Medicines Agency (EMA) have full availability (the product gained access on the public reimbursement list without any restrictions to the patient population). In Poland, that figure drops to 8%, according to a report published by the European Federation of Pharmaceutical Industries. Meanwhile, there is a tremendous difference in the gap between an oncology therapy receiving marketing authorization and a formal positive reimbursement decision, ranging from an average of 86 days in Denmark to 981 days in Latvia.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： What the US credit downgrade means for the economy, your finances

WSS

Scientists grapple with ethics of stem cell research

US jobless claims fall again as labor market continues to flash strength

Judge denies Trump's request for new trial in E. Jean Carroll case

Mega Millions pot grows to $1.25 billion after no winner

5 important ways Henrietta Lacks changed medical science

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

focus

knowledge

knowledge

Virginia high school admissions case could be legal follow

'CMA Fest' 2023: How to watch, who is performing and more

Guidelines to prevent youth baseball injuries need more muscle

Physician groups backed by private equity giant lobby on mergers

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Psychedelics group wrestles with new pharma identity

'CMA Fest' 2023: How to watch, who is performing and more

Anesthesiologist group: stop taking Ozempic before surgery

Mystery swirls around US soldier who entered North Korea days ago, officials say

entertainment

Vertex non

What the airline industry can learn from medicine

New safety details link Apellis eye drug to rare cases of blindness

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Are infertility treatments 'essential' during the Covid

Caribou posts encouraging results on off

explore

hotspot

entertainment

hotspot